Navigation Links
GenturaDx Announces Formation of Scientific Advisory Board
Date:11/22/2011

HAYWARD, Calif., Nov. 22, 2011 /PRNewswire/ -- Molecular diagnostics company GenturaDx announced the creation of its scientific advisory board with the appointment of three initial members: Dr. Keith Jerome, M.D., Ph.D., Dr. Steven Miller, M.D., Ph.D., and Dr. Gregory Tsongalis, Ph.D., H.C.L.D., F.A.C.B. The board will provide expert perspectives across science, laboratory medicine and the commercial market related to initial test development and future applications of the company's proprietary IDbox™. The IDbox system is set to begin clinical trials in 2012.

"We are honored to have attracted these renowned scientists and industry leaders who bring a broad perspective to our work and will lend their expertise enabling GenturaDx to bring its fully integrated platform into the clinical laboratory," said Dr. Tsongalis, Senior Vice President of Research and Development.

Dr. Jerome is a widely published expert on herpes simplex virus (HSV) and viral infections more generally. He currently serves as the Director of the Molecular Virology Laboratory in the Department of Laboratory Medicine, and as Associate Professor in Laboratory Medicine at the University of Washington in Seattle, WA.  Dr. Jerome is an Associate Editor of Diagnostic Microbiology and Infectious Diseases and on the Editorial Advisory Board of the Journal of Infectious Diseases.

Dr. Miller is the Medical Director of the UCSF Clinical Microbiology Laboratory and is Assistant Professor in the Department of Laboratory Medicine at the University of California in San Francisco, CA.  His research focuses on the use of molecular methods for diagnosis and monitoring of infectious disease and the evaluation of clinical utility of new test methods, with resulting changes in patient management and improvements in patient care.

Dr. Tsongalis is a High Complexity Clinical Laboratory Director, a Fellow in the Academy of Clinical Biochemistry and serves as the Director of Molecular Pathology in the Department of Pathology at the Dartmouth-Hitchcock Medical Center in Lebanon, NH. He also serves as Co-Director of the Pathology Translational Research Core Facility and Pharmacogenomics Program, Dartmouth-Hitchcock Medical Center. Tsongalis is on the editorial board of Archives of Pathology and Laboratory Medicine, Journal of Clinical Virology, Journal of Molecular Diagnostics and Clinical Chemistry and Laboratory Medicine. His area of expertise is in clinical molecular diagnostic applications for genetic, hematologic, infectious and neoplastic diseases.

"The ability of GenturaDx to attract industry leaders like Drs. Jerome, Miller and Tsongalis, further validates GenturaDx's innovative technology and continual progress," said GenturaDx's CEO Mark Bagnall. "We are thrilled to call them our advisors."

About GenturaDx

GenturaDx is a molecular diagnostic company focused on making high-performance molecular diagnostics both affordable and practical for any laboratory to perform. The company is developing a fully integrated, automated instrument that conducts testing using a single-use cassette. This platform will make rapid, high-quality molecular diagnostics accessible to hospitals and patients worldwide – circumventing long-standing barriers of costs, automation and performance. GenturaDx's compact, self-contained platform incorporates sample preparation with proprietary, real-time PCR amplification and detection, reducing the risk of contamination and saving time. The platform's unique engineering design and intuitive interface relies on semi-batch processing capability while improving clinical value by offering multiple molecular targets in a single test. For more information, go to www.GenturaDx.com.


'/>"/>
SOURCE GenturaDx
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... CITY, UTAH. (PRWEB) , ... May 25, 2016 , ... ... in healthcare information exchange, today announced that Charles W. Stellar has been named by ... WEDI’s interim CEO since January 2016. As an executive leader with more than 35 ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding ... has granted the company’s orphan drug designation request covering BHV-4157 for the treatment ... by the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder ...
(Date:5/24/2016)... Israel , May 24, 2016   MedyMatch Technology ... physicians with artificial intelligence, real-time decision support tools in the ... present at the 2016 Israeli Advanced Technology Industries (IATI) BioMed ... Israel,s 15th National Life Sciences and ... at the David Intercontinental Hotel in Tel Aviv, ...
(Date:5/24/2016)... Maryland (PRWEB) , ... May 24, 2016 , ... ... of a newly re-branded identity. The new Media Cybernetics corporate branding reflects a ... world of imaging and image analysis. The re-branding components include a crisp, refreshed ...
Breaking Biology Technology:
(Date:3/14/2016)... March 14, 2016 http://www.apimages.com ... --> - Renvoi : image disponible via ... --> --> DERMALOG, le ... de nouveaux lecteurs d,empreintes digitales pour l,enregistrement des ... sera utilisé pour produire des cartes d,identité aux ...
(Date:3/11/2016)... --> --> ... Recognition Market by Technology (Pattern Recognition), by Component (Hardware, ... Type (On-Premises and Cloud), by Industry Vertical and by ... the global market is expected to grow from USD ... 2020, at a CAGR of 19.1%. , ...
(Date:3/10/2016)... , March 10, 2016   Unisys Corporation (NYSE: ... Border Protection (CBP) is testing its biometric identity solution ... Diego to help identify certain non-U.S. citizens leaving ... The test, designed to help determine the efficiency and accuracy ... in February and will run until May 2016. --> ...
Breaking Biology News(10 mins):